Recurrent Intrahepatic Cholangiocarcinoma: A 10-Point Score to Predict Post-Recurrence Survival and Guide Treatment of Recurrence-Reference-Cited by-同舟云学术

Recurrent Intrahepatic Cholangiocarcinoma: A 10-Point Score to Predict Post-Recurrence Survival and Guide Treatment of Recurrence

Published:2024-03-23 Issue:7 Volume:31 Page:4427-4435
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Tsilimigras Diamantis I.,Endo Yutaka,Guglielmi Alfredo,Aldrighetti Luca,Weiss Matthew,Bauer Todd W.,Popescu Irinel,Poultsides George A.,Maithel Shishir K.,Marques Hugo P.,Martel Guillaume,Pulitano Carlo,Shen Feng,Cauchy François,Koerkamp Bas Groot,Endo Itaru,Pawlik Timothy M.^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1245/s10434-024-15210-2.pdf

Reference19 articles.

1. Singal AK, Vauthey JN, Grady JJ, Stroehlein JR. Intra-hepatic cholangiocarcinoma–frequency and demographic patterns: thirty-year data from the M.D. Anderson Cancer Center. J Cancer Res Clin Oncol. 2011;137(7):1071–8.

2. Wu L, Tsilimigras DI, Paredes AZ, et al. Trends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the USA: facility type is associated with margin status, use of lymphadenectomy and overall survival. World J Surg. 2019;43(7):1777–87.

3. Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and Prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg. 2014;149(6):565–74.

4. Benson AB, D’Angelica MI, Abrams T, et al. NCCN guidelines(R) insights: biliary tract cancers, version 2.2023. J Natl Compr Cancer Netw. 2023;21(7):694–704.

5. Tsilimigras DI, Sahara K, Wu L, et al. Very early recurrence after liver resection for intrahepatic cholangiocarcinoma: considering alternative treatment approaches. JAMA Surg. 2020;155(9):823–31.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with prognosis and staging of intrahepatic cholangiocarcinoma;Journal of Cancer Metastasis and Treatment;2024-07-10

2. ASO Author Reflections: ICC PRS Score: Clinically Useful Tool to Predict Post-recurrence Survival and Guide Management of Recurrent Intrahepatic Cholangiocarcinoma;Annals of Surgical Oncology;2024-04-11